Arbor Pharmaceuticals Revenue and Competitors

Atlanta, GA USA

Location

$40.4M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Arbor Pharmaceuticals's estimated annual revenue is currently $22.5M per year.(i)
  • Arbor Pharmaceuticals's estimated revenue per employee is $201,000
  • Arbor Pharmaceuticals's total funding is $40.4M.

Employee Data

  • Arbor Pharmaceuticals has 112 Employees.(i)
  • Arbor Pharmaceuticals grew their employee count by -7% last year.

Arbor Pharmaceuticals's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
ControllerReveal Email/Phone
3
V.P. Regulatory Affairs, Quality, and ManufacturingReveal Email/Phone
4
DirectorReveal Email/Phone
5
Senior Director Hospital & Specialty MarketingReveal Email/Phone
6
Director, MarketingReveal Email/Phone
7
Director Financial Planning and AnalysisReveal Email/Phone
8
National Business Director Hospital SpecialtyReveal Email/Phone
9
Director, Clinical DevelopmentReveal Email/Phone
10
Director, Sales OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.5M1228%N/AN/A
#2
$10.7M53-17%N/AN/A
#3
$9.2M462%N/AN/A
#4
$24.1M1205%N/AN/A
#5
$7.2M36-20%N/AN/A
#6
$27.7M138-30%N/AN/A
#7
$39.8M19837%N/AN/A
#8
$0.5M525%$50MN/A
#9
$13.7M68-7%N/AN/A
#10
$10.3M5111%N/AN/A
Add Company

What Is Arbor Pharmaceuticals?

Arbor Pharmaceuticals is dedicated to introducing and growing unique pharmaceutical brands that have features closely aligned with those desired by pediatricians and their patients. Specifically, Arbor will initially focus on acute care medicines that incorporate well characterized (safe and effective) molecules with novel delivery systems to enhance the product profile.

keywords:N/A

$40.4M

Total Funding

112

Number of Employees

$22.5M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Arbor Pharmaceuticals News

2022-04-20 - NovaQuest's Arbor, Comar Sue Amneal to Block Copies of ...

NovaQuest Capital's Azurity Pharmaceuticals Inc., its Arbor unit, and their business partner, Morgan Stanley's Comar LLC, filed a lawsuit...

2022-04-17 - Onchocerciasis Market To Witness High Growth in Near ...

Merck. Co., Inc, Galderma Laboratories, L.P., Arbor Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Medicines Development for Global...

2022-04-17 - Arbor, Lupin End IP Suit Over Planned Blood Pressure Generic

"Plaintiffs Arbor Pharmaceuticals LLC and Takeda Pharmaceutical Co. Ltd., and defendants Lupin Ltd. and Lupin Pharmaceuticals Inc.,...

2010-11-12 - Arbor Pharmaceuticals Completes $34.8M Financing

Arbor Pharmaceuticals, an Atlanta, GA-based specialty pharmaceutical company, completed a $34.8m financing. This included a $17.5m investment in the form of Series B Preferred Stock led by Signet Healthcare Partners, LLC. The remainder of the financing was provided in the form of a term loan by ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.5M1140%N/A
#2
$16.8M1165%N/A
#3
$24.5M1228%N/A
#4
$34M12642%N/A
#5
$33.1M1324%N/A